ATHERSYS, INC / NEW ATHX Income Statement

Athersys, inc / new (ATHX)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues
Revenues
Revenues
-	-	-	-	-	-	-	-	-	-	399	669	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
0	287	-361	4,262	1,445	1,513	2,321	19,391	1,066	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract revenue from Healios
-	-	-	-	-	-	-	-	-	-	-	-	28	-	150	136	15,124	10,104	39	49	106	-	75	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalty and contract revenue
-	-	-	-	-	-	-	-	-	-	-	-	1,232	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36	44	-	87	194	84	2,024	623	2,270	2,463	2,303	2,071	2,140	2,501	1,601	1,519
Grant revenue
-	-	-	-	-	-	-	-	-	-	-	-	210	-	161	459	334	501	357	167	625	104	218	352	663	530	534	377	242	265	392	387	284	262	283	295	489	395	352
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	1,470	-	311	595	15,458	10,605	396	216	731	235	293	388	707	920	621	571	326	2,289	1,015	2,657	2,747	2,565	2,354	2,435	2,990	1,996	1,871
Costs and expenses
Research and development
12,095	7,635	8,856	11,139	11,415	10,168	9,545	10,093	8,850	12,134	5,441	4,633	5,633	7,087	5,263	5,824	6,664	5,298	5,089	5,261	5,668	5,611	5,775	5,754	6,226	5,112	4,689	5,107	5,576	4,935	4,105	5,027	5,569	5,570	4,328	4,444	4,588	4,342	3,405
General and administrative
3,474	2,447	2,958	2,867	3,106	2,849	2,556	2,382	2,655	2,075	2,113	2,207	2,071	2,006	1,830	1,985	2,014	1,785	1,941	1,924	1,886	1,606	1,695	1,827	1,781	1,553	1,450	1,555	1,507	1,253	1,079	1,162	1,259	1,195	1,110	1,392	1,219	1,329	1,483
Depreciation
190	190	167	157	184	282	196	191	186	176	177	167	164	133	114	67	68	66	66	65	70	87	91	93	89	89	86	86	85	84	81	80	75	76	75	67	60	71	70
Total costs and expenses
15,759	10,272	11,981	14,163	14,705	13,299	12,297	12,666	11,691	14,385	7,731	7,007	7,868	9,226	7,207	7,876	8,746	-	7,096	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on Business Interruption Insurance Recovery
-	-	0	0	-	234	0	20	363	-	-	-	-	-	682	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total costs and expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,250	7,624	-	7,561	7,674	8,096	6,754	6,225	6,748	7,168	6,272	5,265	6,269	6,903	6,841	5,513	5,903	5,867	5,742	4,958
Loss from operations
-15,759	-9,985	-12,342	-9,901	-13,260	-11,552	-9,976	6,745	-10,262	-13,215	-7,332	-6,338	-6,398	-8,243	-6,214	-7,281	6,712	3,456	-6,700	-7,034	-6,893	-7,069	-7,268	-7,286	-7,389	-5,834	-5,604	-6,177	-6,842	-3,983	-4,250	-3,612	-4,156	-4,276	-3,159	-3,468	-2,877	-3,746	-3,087
Income from change in fair value of warrants, net
-	-	-	-	-	-	-	-	-	0	0	0	-728	-1,132	-191	-301	2,181	-164	-255	-5,957	5,604	-256	-2,540	-7,919	4,124	3,971	6	-216	2,563	-	-	-	-	-	-	-	-	-	-
Other income, net
115	62	327	213	304	231	236	188	107	115	89	71	39	-19	7	11	210	-22	-79	25	15	7	8	42	29	10	-4	15	17	-308	-70	-5	-755	-710	807	212	-1,087	11	-47
Loss before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-7,130	-6,016	-6,969	4,741	3,598	-6,524	-1,052	-12,482	-	-4,720	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-3	-12	-13	-9	-	-27	-17	-	-	-1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proportional share of comprehensive loss of equity method investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-28	-	-	-	-	-	-
Proportional share of comprehensive (loss) income of equity method investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	19	12	-	-
Unrealized loss on available-for-sale securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-61	-5	19	21	-	-
Other comprehensive income (loss) items
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38	33	-	-
Net loss and comprehensive loss
-15,644	-9,923	-12,015	-9,688	-12,956	-11,321	-9,740	6,933	-10,155	-13,100	-7,243	-6,267	-5,631	-7,127	-6,004	-6,956	4,750	3,592	-6,497	-1,035	-12,482	-6,554	-4,719	675	-11,484	-	-	-	-	-3,237	-3,449	-3,713	-4,364	-4,321	-2,341	-3,185	-3,897	-	-
Net loss per share, basic and diluted (in dollars per share)
-0.10	-	-0.08	-	-0.09	-	-0.07	-	-0.08	-	-0.06	-	-0.06	-	-	-	0.06	-	-	-	-0.16	-	-	-	-0.15	-	-	-	-0.18	-	-0.12	-0.13	-0.17	-0.17	-0.10	-0.14	-0.18	-0.19	-0.16
(Expense) income from change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	871	-96	575	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	33	34	47	57
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,614	-5,946	-9,388	-3,237	-3,449	-3,713	-4,336	-4,252	-2,341	-3,223	-3,930	-3,688	-3,077
Net (loss) income per share, basic (in dollars per share)
-	-	-	-0.06	-	-	-	0.05	-	-	-	-0.06	-	-	-0.07	-0.08	-	-	-0.08	-0.01	-	-	-0.06	0.01	-	-	-0.10	-0.11	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding, basic (in shares)
-	-	-	150,163	-	-	-	138,225	-	-	-	111,820	-	-	84,928	84,341	83,781	83,409	83,140	82,843	79,180	-	77,320	77,077	-	-	57,646	56,028	-	-	-	-	-	-	-	-	-	-	-
Net (loss) income per share, diluted (in dollars per share)
-	-	-	-0.06	-	-	-	0.05	-	-	-	-0.06	-	-	-0.07	-0.08	-	-	-0.08	-0.05	-	-	-0.08	-0.04	-	-	-0.10	-0.11	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding, diluted (in shares)
-	-	-	150,163	-	-	-	139,375	-	-	-	111,820	-	-	85,896	85,416	83,865	85,235	83,425	83,562	79,180	-	78,349	78,778	-	-	59,248	57,841	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding, basic and diluted (in shares)
162,715	-	153,096	-	145,964	-	138,930	-	126,897	-	114,515	-	102,047	-	-	-	-	-	-	-	-	-	-	-	75,852	-	-	-	53,455	-	29,800	29,405	25,547	24,075	23,502	23,502	21,874	18,929	18,929
Royalty and other contract revenue
Revenues
-	-	0	0	-	157	312	591	401	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grant revenue
Revenues
0	36	7	69	4	89	103	45	317	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-